Cargando…
Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis: A Narrative Review
Although corticosteroids are the standard first-line therapy for pulmonary sarcoidosis, long-term and high-dose use of these drugs are associated with increased risk of adverse events and high healthcare utilization costs. Treatment guidelines for pulmonary sarcoidosis indicate that off-label immuno...
Autores principales: | Mirsaeidi, Mehdi, Baughman, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8861221/ https://www.ncbi.nlm.nih.gov/pubmed/35113366 http://dx.doi.org/10.1007/s41030-022-00181-0 |
Ejemplares similares
-
Results From a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Repository Corticotropin Injection for the Treatment of Pulmonary Sarcoidosis
por: Mirsaeidi, Mehdi, et al.
Publicado: (2023) -
Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017) -
Management of repository corticotrophin injection therapy for pulmonary sarcoidosis: a Delphi study
por: Rahaghi, Franck F., et al.
Publicado: (2020) -
A Narrative Review of Repository Corticotropin Injection for the Treatment of Systemic Lupus Erythematosus
por: Askanase, Anca D., et al.
Publicado: (2022) -
Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis
por: Bindra, Jas, et al.
Publicado: (2022)